CLINICAL_TRIALS
trial_result
· 2012-10-23
Clinical Trial Update: Follow-Up Study for Exubera
Summary
A follow-up study of Exubera (insulin inhalation powder) in people with diabetes mellitus completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus | Status: COMPLETED | Results posted: 2012-10-23